Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Сен. 27, 2022
Abstract
Digestive
system
diseases
arise
primarily
through
the
interplay
of
genetic
and
environmental
influences;
there
is
an
urgent
need
in
elucidating
pathogenic
mechanisms
these
deploy
personalized
treatments.
Traditional
long-established
model
systems
rarely
reproduce
either
tissue
complexity
or
human
physiology
faithfully;
shortcomings
underscore
for
better
models.
Organoids
represent
a
promising
research
model,
helping
us
gain
more
profound
understanding
digestive
organs;
this
can
also
be
used
to
provide
patients
with
precise
individualized
treatment
build
rapid
vitro
test
models
drug
screening
gene/cell
therapy,
linking
basic
clinical
treatment.
Over
past
few
decades,
use
organoids
has
led
advanced
composition
each
organ
facilitated
disease
modeling,
chemotherapy
dose
prediction,
CRISPR-Cas9
intervention,
high-throughput
screening,
identification
SARS-CoV-2
targets,
infection.
However,
existing
mainly
include
epithelial
system.
In
order
reveal
mechanism
diseases,
it
necessary
establish
completer
physiological
organoid
model.
Combining
techniques
treatments
different
formulations
approach
that
requires
further
exploration.
This
review
highlights
advancements
field
technology
from
perspectives
modeling
therapy.
The
human
intestinal
microbiome
substantially
affects
health
and
resistance
to
infections
in
its
dynamic
composition
varying
release
of
microbial-derived
metabolites.
Short-chain
fatty
acids
(SCFA)
produced
by
commensal
bacteria
through
fermentation
indigestible
fibres
are
considered
key
regulators
orchestrating
the
host
immune
response
microbial
colonization
regulating
phagocytosis,
chemokine
central
signalling
pathways
cell
growth
apoptosis,
thereby
shaping
functionality
epithelial
barrier.
Although
research
last
decades
provided
valuable
insight
into
pleiotropic
functions
SCFAs
their
capability
maintain
health,
mechanistic
details
on
how
act
across
different
types
other
organs
not
fully
understood.
In
this
review,
we
provide
an
overview
various
cellular
metabolism,
emphasizing
orchestration
along
gut–brain,
gut–lung
gut–liver
axes.
We
discuss
potential
pharmacological
use
inflammatory
diseases
highlight
new
options
relevant
three-dimensional
organ
models
investigate
validate
biological
more
detail.
Cell,
Год журнала:
2022,
Номер
185(15), С. 2756 - 2769
Опубликована: Июль 1, 2022
For
decades,
insight
into
fundamental
principles
of
human
biology
and
disease
has
been
obtained
primarily
by
experiments
in
animal
models.
While
this
allowed
researchers
to
understand
many
biological
processes
great
detail,
some
developmental
mechanisms
have
proven
difficult
study
due
inherent
species
differences.
The
advent
organoid
technology
more
than
10
years
ago
established
laboratory-grown
organ
tissues
as
an
additional
model
system
recapitulate
human-specific
aspects
biology.
use
3D
organoids,
well
other
advances
single-cell
technologies,
revealed
unprecedented
insights
mechanisms,
especially
those
that
distinguish
humans
from
species.
This
review
highlights
novel
with
a
focus
on
how
generated
better
understanding
development
disease.
Translational Neurodegeneration,
Год журнала:
2023,
Номер
12(1)
Опубликована: Дек. 15, 2023
Parkinson's
disease
(PD)
is
one
of
the
most
prevalent
neurodegenerative
diseases.
The
typical
symptomatology
PD
includes
motor
symptoms;
however,
a
range
nonmotor
symptoms,
such
as
intestinal
issues,
usually
occur
before
symptoms.
Various
microorganisms
inhabiting
gastrointestinal
tract
can
profoundly
influence
physiopathology
central
nervous
system
through
neurological,
endocrine,
and
immune
pathways
involved
in
microbiota-gut-brain
axis.
In
addition,
extensive
evidence
suggests
that
gut
microbiota
strongly
associated
with
PD.
This
review
summarizes
latest
findings
on
microbial
changes
their
clinical
relevance,
describes
underlying
mechanisms
which
bacteria
may
mediate
PD,
discusses
correlations
between
microbes
anti-PD
drugs.
this
outlines
status
research
therapies
for
future
directions
PD-gut
research.
Theranostics,
Год журнала:
2024,
Номер
14(2), С. 788 - 818
Опубликована: Янв. 1, 2024
Human
organoids-on-chips
(OrgOCs)
are
the
synergism
of
human
organoids
(HOs)
technology
and
microfluidic
organs-on-chips
(OOCs).OOCs
can
mimic
extrinsic
characteristics
organs,
such
as
environmental
clues
living
tissue,
while
HOs
more
amenable
to
biological
analysis
genetic
manipulation.By
spatial
cooperation,
OrgOCs
served
3D
organotypic
models
allowing
them
recapitulate
critical
tissue-specific
properties
forecast
responses
outcomes.It
represents
a
giant
leap
forward
from
regular
2D
cell
monolayers
animal
in
improved
ecological
niche
modeling.In
recent
years,
have
offered
potential
promises
for
clinical
studies
advanced
preclinical-to-clinical
translation
medical
industrial
fields.In
this
review,
we
highlight
cutting-edge
achievements
OrgOCs,
introduce
key
features
architectures,
share
revolutionary
applications
basic
biology,
disease
modeling,
preclinical
assay
precision
medicine.Furthermore,
discuss
how
combine
wide
range
disciplines
with
accelerate
translational
applications,
well
challenges
opportunities
biomedical
research
applications.
Frontiers in Cell and Developmental Biology,
Год журнала:
2021,
Номер
9
Опубликована: Авг. 20, 2021
Colorectal
cancer
(CRC)
is
a
common
worldwide
with
complex
etiology.
Fusobacterium
nucleatum
(
F.
),
an
oral
symbiotic
bacterium,
has
been
linked
CRC
in
the
past
decade.
A
series
of
gut
microbiota
studies
show
that
patients
carry
high
abundance
tumor
tissue
and
fecal,
etiological
have
clarified
role
as
pro-carcinogenic
bacterium
various
stages
CRC.
In
this
review,
we
summarize
biological
characteristics
epidemiological
associations
between
CRC,
then
highlight
mechanisms
by
which
participates
progression,
metastasis,
chemoresistance
affecting
cells
or
regulating
microenvironment
(TME).
We
also
discuss
research
gap
field
give
our
perspective
for
future
studies.
These
findings
will
pave
way
manipulating
to
deal
future.
Annals of the Rheumatic Diseases,
Год журнала:
2021,
Номер
80(12), С. 1575 - 1583
Опубликована: Авг. 23, 2021
Objective
Alteration
of
the
gut
microbiome
has
been
linked
to
pathogenesis
systemic
lupus
erythematosus
(SLE).
However,
a
comprehensive
view
in
SLE
and
its
interaction
with
host
remains
be
revealed.
This
study
aimed
reveal
SLE-associated
changes
by
metagenome-wide
association
(MWAS)
followed
integrative
analysis.
Methods
We
performed
MWAS
based
on
shotgun
sequencing
microbial
DNA
from
Japanese
individuals
(
N
case
=47,
control
=203).
integrated
result
genome-wide
(GWAS)
data
plasma
metabolite
data.
Results
Via
species
level
phylogenetic
analysis,
we
identified
validated
increases
Streptococcus
intermedius
anginosus
patients
SLE.
Microbial
gene
analysis
revealed
-derived
genes
including
one
involved
redox
reaction.
Additionally,
pathways
related
sulfur
metabolism
flagella
assembly
were
altered
an
overlap
enriched
biological
between
metagenome
germline
genome
comparing
GWAS
(ie,
MWAS-GWAS
interaction).
α-diversity
β-diversity
analyses
provided
evidence
dysbiosis
Microbiome-metabolome
positive
dosage
correlation
acylcarnitine
,
taxon.
Conclusion
Our
host,
which
contribute
our
understanding
relationship
npj Biofilms and Microbiomes,
Год журнала:
2023,
Номер
9(1)
Опубликована: Окт. 9, 2023
Abstract
Recent
evidence
suggests
that
some
human
cancers
may
harbor
low-biomass
microbial
ecosystems,
spanning
bacteria,
viruses,
and
fungi.
Bacteria,
the
most-studied
kingdom
in
this
context,
are
suggested
by
these
studies
to
localize
within
cancer
cells,
immune
cells
other
tumor
microenvironment
cell
types,
where
they
postulated
impact
multiple
cancer-related
functions.
Herein,
we
provide
an
overview
of
intratumoral
while
focusing
on
intracellular
their
molecular
activities,
communication
networks,
host
invasion
evasion
strategies,
long-term
colonization
capacity.
We
highlight
how
integration
sequencing-based
spatial
techniques
enable
recognition
bacterial
niches.
discuss
pitfalls,
debates
challenges
decisively
proving
existence
function
microbes,
reaching
a
mechanistic
elucidation
impacts
behavior
treatment
responses.
Together,
causative
understanding
possible
roles
played
bacteria
future
utilization
diagnosis,
patient
stratification,
treatment.
Biosensors,
Год журнала:
2023,
Номер
13(1), С. 136 - 136
Опубликована: Янв. 13, 2023
The
human
gut
is
responsible
for
food
digestion
and
absorption.
Recently,
growing
evidence
has
shown
its
vital
role
in
the
proper
functioning
of
other
organs.
Advances
microfluidic
technologies
have
made
a
significant
impact
on
biomedical
field.
Specifically,
organ-on-a-chip
technology
(OoC),
which
become
popular
substitute
animal
models,
capable
imitating
complex
systems
vitro
been
used
to
study
pathology
pharmacology.
Over
past
decade,
reviews
published
focused
more
applications
prospects
gut-on-a-chip
(GOC)
technology,
but
challenges
solutions
these
limitations
were
often
overlooked.
In
this
review,
we
cover
physiology
review
engineering
approaches
GOC.
Fundamentals
GOC
models
including
materials
fabrication,
cell
types,
stimuli
microbiota
are
thoroughly
reviewed.
We
discuss
present
model
applications,
challenges,
possible
technology.